2-(2-FUROYL)-LEU-ILE-GLY-ARG-LEU-ORN-NH2
2-(2-FUROYL)-LEU-ILE-GLY-ARG-LEU-ORN-NH2 Basic information
- Product Name:
- 2-(2-FUROYL)-LEU-ILE-GLY-ARG-LEU-ORN-NH2
- Synonyms:
-
- PAR-2 AGONIST II
- PROTEINASE ACTIVATED RECEPTOR-2 AGONIST II
- 2-(2-FUROYL)-LEU-ILE-GLY-ARG-LEU-ORN-NH2
- 2-(2-FUROYL)-LIGRLOAMIDE
- 2-(2-FUROYL)-PAR-2 (2-6)-ORN AMIDE (MOUSE, RAT)
- 2F-LIGRLO-AMIDE
- 2-FUROYL-LEU-ILE-GLY-ARG-LEU-ORN-NH2
- 2-FUROYL-LIGRLO-AMIDE
- CAS:
- 729589-58-6
- MF:
- C36H63N11O8
- MW:
- 777.95
- Mol File:
- 729589-58-6.mol
2-(2-FUROYL)-LEU-ILE-GLY-ARG-LEU-ORN-NH2 Chemical Properties
- Density
- 1.33±0.1 g/cm3(Predicted)
- storage temp.
- -20°C
- solubility
- Soluble in H2O
- pka
- 12.91±0.46(Predicted)
- form
- powder
- color
- white
- Water Solubility
- Soluble to 1 mg/ml in water
2-(2-FUROYL)-LEU-ILE-GLY-ARG-LEU-ORN-NH2 Usage And Synthesis
Uses
2-Furoyl-LIGRLO-amide trifluoroacetate salt may be used as a protease-activated receptor 2 (PAR2) agonist in endothelial progenitor cells (EPCs) and in transient receptor potential cation channel subfamily V member (TRPV4)-transfected HEK293t cells.
General Description
2-Furoyl-LIGRLO-amide trifluoroacetate salt is a peptide that acts as a proteinase-activated receptor-2 (PAR2) agonist, and contains a furoyl group addition at its N-terminal.
Biological Activity
potent and selective par2 receptor agonist (pd2 = 7.0). causes a dose-dependent relaxation of murine femoral arteries.
Biochem/physiol Actions
2-Furoyl-LIGRLO-amide is a potent and selective protease-activated receptor 2 (PAR2) agonist. PAR-2 activation is associated with increases in cAMP and intracellular Ca(2+). Immunoblot analysis revealed increases in phosphorylation of epidermal growth factor (EGF) receptor (EGFR) tyrosine kinase, Src, Pyk2, cRaf, and ERK1/2 in response to PAR-2 activation. 2-Furoyl-LIGRLO-amide is nearly 100-fold more potent than SLIGRL-NH2 (Cat. No. S9317). 2-Furoyl-LIGRLO-amide caused both an endothelium-dependent relaxation and an endothelium-independent contraction. It produced delayed (6 hours later) facilitation of capsaicin-evoked visceral nociception, an effect being much more potent than SLIGRL-NH2. Such effects were mimicked by i.col. trypsin. 2-f-LIGRL-NH2, coadministered repeatedly with caerulein six times in total, abolished the caerulein-evoked abdominal hyperalgesia/allodynia in WT, but not PAR2-KO, mice. Repeated doses of 2-f-LIGRL-NH2 moderately attenuated the severity of caerulein-induced pancreatitis in WT animals. It induced a similar dose-dependent increase in Ca2 levels in the presence and absence of b-arrestins.
storage
Store at -20°C
2-(2-FUROYL)-LEU-ILE-GLY-ARG-LEU-ORN-NH2Supplier
- Tel
- 821-50328103-801 18930552037
- 3bsc@sina.com
- Tel
- 21-61263452 13641803416
- ymbetter@glbiochem.com
- Tel
- 021-54306202 13764082696
- info@hanhongsci.com
- Tel
- 021-50135380
- shchemsky@sina.com
- Tel
- 0510-85629785 18013409632
- sales@reading-chemicals.com